238 related articles for article (PubMed ID: 25527370)
1. Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study.
di Giuseppe R; Kühn T; Hirche F; Buijsse B; Dierkes J; Fritsche A; Kaaks R; Boeing H; Stangl GI; Weikert C
Eur J Epidemiol; 2015 Feb; 30(2):131-41. PubMed ID: 25527370
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 and risk of incident stroke in community-living adults.
Panwar B; Jenny NS; Howard VJ; Wadley VG; Muntner P; Kissela BM; Judd SE; Gutiérrez OM
Stroke; 2015 Feb; 46(2):322-8. PubMed ID: 25563643
[TBL] [Abstract][Full Text] [Related]
3. Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study.
di Giuseppe R; Kühn T; Hirche F; Buijsse B; Dierkes J; Fritsche A; Kaaks R; Boeing H; Stangl GI; Weikert C
PLoS One; 2015; 10(7):e0133580. PubMed ID: 26193703
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
[TBL] [Abstract][Full Text] [Related]
5. Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
Panwar B; Judd SE; Wadley VG; Jenny NS; Howard VJ; Safford MM; Gutiérrez OM
JAMA Cardiol; 2018 Apr; 3(4):318-325. PubMed ID: 29516098
[TBL] [Abstract][Full Text] [Related]
6. Plasma fibroblast growth factor 23, parathyroid hormone, 25-hydroxyvitamin D3, and risk of heart failure: a prospective, case-cohort study.
di Giuseppe R; Buijsse B; Hirche F; Wirth J; Arregui M; Westphal S; Isermann B; Hense HW; Dierkes J; Boeing H; Stangl GI; Weikert C
J Clin Endocrinol Metab; 2014 Mar; 99(3):947-55. PubMed ID: 24423292
[TBL] [Abstract][Full Text] [Related]
7. Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study.
Rohrmann S; Garmo H; Malmström H; Hammar N; Jungner I; Walldius G; Van Hemelrijck M
Atherosclerosis; 2016 Aug; 251():85-93. PubMed ID: 27289190
[TBL] [Abstract][Full Text] [Related]
8. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg).
Li K; Kaaks R; Linseisen J; Rohrmann S
Heart; 2012 Jun; 98(12):920-5. PubMed ID: 22626900
[TBL] [Abstract][Full Text] [Related]
9. Presence of gallstones and the risk of cardiovascular diseases: The EPIC-Germany cohort study.
Wirth J; di Giuseppe R; Wientzek A; Katzke VA; Kloss M; Kaaks R; Boeing H; Weikert C
Eur J Prev Cardiol; 2015 Mar; 22(3):326-34. PubMed ID: 24177267
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.
Boekholdt SM; Peters RJ; Day NE; Luben R; Bingham SA; Wareham NJ; Hack CE; Reitsma PH; Khaw KT
Am J Med; 2004 Sep; 117(6):390-7. PubMed ID: 15380495
[TBL] [Abstract][Full Text] [Related]
11. Association of serum markers of oxidative stress with myocardial infarction and stroke: pooled results from four large European cohort studies.
Xuan Y; Bobak M; Anusruti A; Jansen EHJM; Pająk A; Tamosiunas A; Saum KU; Holleczek B; Gao X; Brenner H; Schöttker B
Eur J Epidemiol; 2019 May; 34(5):471-481. PubMed ID: 30406496
[TBL] [Abstract][Full Text] [Related]
12. Soluble klotho and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Larsson TE; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2015 Oct; 242(2):483-9. PubMed ID: 26298739
[TBL] [Abstract][Full Text] [Related]
13. Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)-Germany study.
Kühn T; Kaaks R; Teucher B; Hirche F; Dierkes J; Weikert C; Katzke V; Boeing H; Stangl GI; Buijsse B
PLoS One; 2013; 8(7):e69080. PubMed ID: 23935930
[TBL] [Abstract][Full Text] [Related]
14. Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones.
Taylor EN; Hoofnagle AN; Curhan GC
Clin J Am Soc Nephrol; 2015 Apr; 10(4):667-75. PubMed ID: 25623233
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults.
Paul S; Wong M; Akhabue E; Mehta RC; Kramer H; Isakova T; Carnethon MR; Wolf M; Gutiérrez OM
J Am Heart Assoc; 2021 Aug; 10(16):e020196. PubMed ID: 34387090
[TBL] [Abstract][Full Text] [Related]
16. Plasma resistin levels and risk of myocardial infarction and ischemic stroke.
Weikert C; Westphal S; Berger K; Dierkes J; Möhlig M; Spranger J; Rimm EB; Willich SN; Boeing H; Pischon T
J Clin Endocrinol Metab; 2008 Jul; 93(7):2647-53. PubMed ID: 18460562
[TBL] [Abstract][Full Text] [Related]
17. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
[TBL] [Abstract][Full Text] [Related]
18. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.
Floegel A; Kühn T; Sookthai D; Johnson T; Prehn C; Rolle-Kampczyk U; Otto W; Weikert C; Illig T; von Bergen M; Adamski J; Boeing H; Kaaks R; Pischon T
Eur J Epidemiol; 2018 Jan; 33(1):55-66. PubMed ID: 29181692
[TBL] [Abstract][Full Text] [Related]
19. The Ratio of Regulatory (FOXP3+) to Total (CD3+) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabetics.
Barth SD; Kaaks R; Johnson T; Katzke V; Gellhaus K; Schulze JJ; Olek S; Kühn T
EBioMedicine; 2016 Sep; 11():151-156. PubMed ID: 27499494
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.
Tang WH; Wu Y; Hartiala J; Fan Y; Stewart AF; Roberts R; McPherson R; Fox PL; Allayee H; Hazen SL
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):516-22. PubMed ID: 22075249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
